Tag

Acute Myeloid Leukemia

All articles tagged with #acute myeloid leukemia

Leukemia patient weds in a five-day whirlwind ceremony
health1 month ago

Leukemia patient weds in a five-day whirlwind ceremony

Alana Matthews, a 27-year-old diagnosed with acute myeloid leukemia, organized an impromptu wedding with her partner Charlie in just five days after doctors said there were no further treatment options, a day described as emotional and beautiful. She died weeks later, and her best friend Katie Powell has since raised thousands for Blood Cancer UK to honor her memory and encourage others to trust their instincts and seek answers when something feels wrong.

Pregnant Woman Battles Aggressive Leukemia as Baby Defies Odds
health2 months ago

Pregnant Woman Battles Aggressive Leukemia as Baby Defies Odds

Amy De Silva, a 39-year-old cancer nurse, was diagnosed with acute myeloid leukemia while pregnant and underwent four rounds of chemotherapy starting in early 2025, facing sepsis complications and uncertain prospects for her unborn son. Despite doctors’ fears, her baby Chester was born six weeks early in June 2025 and thrived; Amy is now in remission and will have regular follow-ups for two years. Her twin brother is also raising funds for the hospital that treated her.

Socioeconomic Factors Hinder Access to AML Stem Cell Transplants
health1 year ago

Socioeconomic Factors Hinder Access to AML Stem Cell Transplants

A study by Fred Hutchinson Cancer Center highlights how socioeconomic factors hinder access to bone marrow transplants for acute myeloid leukemia (AML) patients, leading to higher mortality rates in disadvantaged communities. The research, presented at the American Society of Hematology's annual meeting, found that patients from areas with lower education levels and higher poverty rates were less likely to receive transplants. However, survival rates post-transplant were similar across socioeconomic backgrounds, suggesting access barriers rather than treatment efficacy are the main issue.

"Breakthrough: UT Scientists Find Key to Stalling Cancer Growth"
health-and-medicine2 years ago

"Breakthrough: UT Scientists Find Key to Stalling Cancer Growth"

Scientists at The University of Texas at Austin have discovered a potential new way to treat acute myeloid leukemia, a particularly aggressive form of cancer. In an experimental study, they were able to curb the cancer's growth without harming healthy cells, providing clues for future drug development and offering a new potential therapeutic target for this hard-to-treat disease.

Paediatrician's Observation Leads to Mum's Cancer Diagnosis
health2 years ago

Paediatrician's Observation Leads to Mum's Cancer Diagnosis

A mother's cancer diagnosis was discovered after her children's pediatrician noticed something was wrong during their visit. She was diagnosed with acute myeloid leukemia and underwent intense chemotherapy, eventually going into remission after a stem cell transplant. Inspired by her own journey, she and her husband founded Luminaries, a nonprofit organization dedicated to supporting cancer survivors in their post-treatment phase by providing self-care kits and resources. Their mission is to ensure that every survivor has access to the tools and support they need.

FDA Imposes Partial Hold on Gilead's Magrolimab Trials for AML
healthcare2 years ago

FDA Imposes Partial Hold on Gilead's Magrolimab Trials for AML

The FDA has placed a partial clinical hold on Gilead's magrolimab, a CD47 candidate for acute myeloid leukemia (AML). Gilead has halted the screening and enrollment of new patients in US trials studying the drug in AML, but patients already enrolled can continue treatment. The hold affects two Phase III studies, ENHANCE-2 and ENHANCE-3, as well as Gilead's expanded access program.

FDA Approves Daiichi Sankyo's Quizartinib as First-Line Treatment for AML with Boxed Warning for Heart Disorders
healthcare2 years ago

FDA Approves Daiichi Sankyo's Quizartinib as First-Line Treatment for AML with Boxed Warning for Heart Disorders

The FDA has approved Daiichi Sankyo's Vanflyta (quizartinib) as a first-line treatment option for patients with FLT3-ITD-positive acute myeloid leukemia (AML). The drug can be used in combination with chemotherapy and as a maintenance monotherapy after initial treatment. A companion diagnostic has also been approved to detect the mutation.

Patient death prompts pause in 2seventy bio's cancer therapy study.
healthcare3 years ago

Patient death prompts pause in 2seventy bio's cancer therapy study.

Seattle Children's has paused a Phase I study of 2seventy bio's CAR-T cell therapy, SC-DARIC33, following the death of a patient who received the therapy at the second dose level. The therapy is being investigated in pediatric and young adult patients with acute myeloid leukemia, and the cause of the adverse event is currently under investigation.